The Valley Desk

NCT07723248 · Interventional trial

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Overall registry status Recruiting

Phase 3

Conditions Metastatic Castration Resistant Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov